National Science Library, Chinese Academy of Sciences
  登录 机构网站 ENGLISH
您当前的位置是:首页->检索结果浏览
排序:
全选
显示: 条结果
1    
Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial 期刊论文

Lancet, The     ISSN:0140-6736  Volume:384  Issue:9940  Page:319-328  

Brose Marcia S Dr;   Nutting Christopher M Prof;   Jarzab Barbara Prof;   Elisei Rossella Prof;   Siena Salvatore MD;   ...

来源数据库: [Web of Science, Science Database],

被引频次:522

文摘信息 获取全文 问图书馆员

2    
Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial 期刊论文

Lancet, The     ISSN:0140-6736  Volume:389  Issue:10064  Page:56-66  

Bruix Jordi Dr;   Qin Shukui Prof;   Merle Philippe Prof;   Granito Alessandro MD;   Huang Yi-Hsiang Prof;   ...

来源数据库: [Web of Science, Scopus, Science Database],

被引频次:683

文摘信息 获取全文 问图书馆员

3    
Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial 期刊论文

The Lancet     ISSN:0140-6736  Volume:391  Issue:10126  Page:1163-1173  

Kudo Masatoshi;   Finn Richard S;   Qin Shukui;   Han Guohong;   Han Kwang-Hyub;   ...

来源数据库: [Web of Science, Scopus, Science Database],

被引频次:309

文摘信息 获取全文 问图书馆员

4    
Adjuvant sorafenib for hepatocellular carcinoma after resection or ablation (STORM): a phase 3, randomised, double-blind, placebo-controlled trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:16  Issue:13  Page:1344-1354  

Bruix Jordi Prof;   Takayama Tadatoshi Prof;   Mazzaferro Vincenzo Prof;   Chau Gar-Yang Prof;   Yang Jiamei Prof;   ...

来源数据库: [Web of Science, Scopus],

被引频次:292

文摘信息 获取全文 问图书馆员

5    
Axitinib versus sorafenib as second-line treatment for advanced renal cell carcinoma: overall survival analysis and updated results from a randomised phase 3 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:14  Issue:6  Page:552-562  

Motzer Robert J Dr;   Escudier Bernard MD;   Tomczak Piotr MD;   Hutson Thomas E DO;   Michaelson M Dror MD;   ...

来源数据库: [Web of Science, Scopus],

被引频次:404

文摘信息 获取全文 问图书馆员

6    
Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial 期刊论文

Journal of Hepatology     ISSN:0168-8278  Volume:57  Issue:4  Page:821-829  

Bruix Jordi;   Raoul Jean-Luc;   Sherman Morris;   Mazzaferro Vincenzo;   Bolondi Luigi;   ...

来源数据库: [Web of Science, Scopus],

被引频次:414

文摘信息 获取全文 问图书馆员

7    
Hepatocellular carcinoma: clinical frontiers and perspectives 期刊论文

Gut   ISSN:0017-5749  Volume:63  Issue:5  Page:844-855  

Bruix Jordi;   Gores Gregory J;   Mazzaferro Vincenzo;  

来源数据库: [Web of Science, Scopus, Science Database],

被引频次:672

文摘信息 获取全文 问图书馆员

8    
CXCR4 inhibition in tumor microenvironment facilitates anti‐programmed death receptor‐1 immunotherapy in sorafenib‐treated hepatocellular carcinoma in mice 期刊论文

Hepatology     ISSN:0270-9139  Volume:61  Issue:5  Page:1591-1602  

Chen Yunching;   Ramjiawan Rakesh R;   Reiberger Thomas;   Ng Mei R;   Hato Tai;   ...

来源数据库: [Web of Science, Scopus],

被引频次:132

文摘信息 获取全文 问图书馆员

9    
Axitinib versus sorafenib as first-line therapy in patients with metastatic renal-cell carcinoma: a randomised open-label phase 3 trial 期刊论文

Lancet Oncology, The     ISSN:1470-2045  Volume:14  Issue:13  Page:1287-1294  

Hutson Thomas E Prof;   Lesovoy Vladimir Prof;   Al-Shukri Salman Prof;   Stus Viktor P Prof;   Lipatov Oleg N Prof;   ...

来源数据库: [Web of Science, Scopus],

被引频次:197

文摘信息 获取全文 问图书馆员

10    
BAYPAN study: A double-blind phase III randomized trial comparing gemcitabine plus sorafenib and gemcitabine plus placebo in patients with advanced pancreatic cancer 期刊论文

Annals of Oncology     ISSN:0923-7534  Volume:23  Issue:11  Page:2799-2805  

Gonçalves A;   Gilabert M;   François E;   Dahan L;   Perrier H;   ...

来源数据库: [Web of Science, Scopus],

被引频次:119

文摘信息 问图书馆员

< 首页 < 上一页 1 2 3 4 5 下一页 >
导出参考文献:×
作者信息:×